| Project/Area Number |
13670553
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Single-year Grants |
|---|
| Section | 一般 |
|---|
| Research Field |
Gastroenterology
|
|---|
| Research Institution | Saitama Medical School |
|---|
Principal Investigator |
OTA Shinichi Saitama Medical School, Medicine, Professor, 医学部, 教授 (30185269)
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
FUJIWARA Kenji Saitama Medical School, Medicine, Professor, 医学部, 教授 (80101088)
ARAI Shin Saitama Medical School, Medicine, Assistant, 医学部, 助手 (20306294)
|
|---|
| Project Period (FY) |
2001 – 2002
|
| Project Status |
Completed (Fiscal Year 2002)
|
| Budget Amount *help |
¥3,500,000 (Direct Cost: ¥3,500,000)
Fiscal Year 2002: ¥1,700,000 (Direct Cost: ¥1,700,000)
Fiscal Year 2001: ¥1,800,000 (Direct Cost: ¥1,800,000)
|
|---|
| Keywords | colon cancer / COX-2 / prostaglandin / VEGF / PPAR / 大腸腺腫 / 受容体 / 血管内皮増殖因子 / PPARγ / マクロファージ |
|---|
| Research Abstract |
Various studies have demonstrated that Non-steroidal anti-inflammatory drugs (NSAIDs) prevent colon cancer formation. However, the mechanisms of these steps have not been elucidated yet while cyclooxygenase (COX-2) has been demonstrated to play an important role in this phenomenon. We investigated the localization of COX-2 in human gastric tumors and possible roles using cell lines. What we found was described below: 1. COX-2 was expressed in mesenchymal cells located at sub-epithelial layer of human colonic adenomas. 2. COX-2 was also expressed in mesenchymal cells located at sub-epithelial layer of human hyperplastic gastric polyps but not in human gastric adenomas. 3. Prostaglandin (PG) E induced vascular endothelial growth factor (VEGF) expression by human macrophages through EP_2 and EP_4 prostaglandin receptors. 4. Cicaprost and iloprost, specific ligands for PGI receptors, also stimulated VEGF production by these cells. 5. A PGJ_2 analogue, a specific ligand for PPARγ, but not a PGI_2 analogue, a specific ligand for PPARδ, showed similar effects. 6. Both a ligand for PPARγ and a ligand for PPARδ but not ligands for PGE receptors or PGI receptors simulated VEGF production by colon cancer cell lines. 7. Rebamipide, an anti-ulcer drug, suppressed membrane PG receptor-mediated but not nuclear receptor-mediated increase of VEGF production by macrophages.
|
